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This study aimed to evaluate the feasibility, acceptability, ceiling and floor effects, reliability, 
and convergent construct validity of the Brazilian version of the Mini Cuestionario de Calidad de 
Vida en la Hipertensión Arterial (MINICHAL). The study included 200 hypertensive outpatients 
in a university hospital and a primary healthcare unit. The MINICHAL was applied in 3.0 (± 1.0) 
minutes with 100% of the items answered. A “ceiling effect” was observed in both dimensions 
and in the total score, as well as evidence of measurement stability (ICC=0.74). The convergent 
validity was confirmed by significant positive correlations between similar dimensions of the 
MINICHAL and the SF-36, and significant negative correlations with the Minnesota Living with 
Heart Failure Questionnaire - MLHFQ, however, correlations between dissimilar constructs were 
also observed. It was concluded that the Brazilian version of the MINICHAL presents evidence of 
reliability and validity when applied to hypertensive outpatients.
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Desempenho psicométrico da versão brasileira do Mini-cuestionario de 
calidad de vida en la hipertensión arterial (MINICHAL)
Este estudo teve como objetivo avaliar a praticabilidade, a aceitabilidade, os efeitos teto 
e chão, a confiabilidade e a validade de constructo convergente da versão brasileira do 
mini - cuestionario de calidad de vida en la hipertensión arterial - Minichal. Participaram do 
estudo 200 pacientes hipertensos, em seguimento ambulatorial, em hospital universitário 
e unidade básica de saúde. O Minichal foi aplicado em 3,0 (±1,0) minutos, com 100% 
dos itens respondidos. Foi observado efeito teto em ambas as dimensões e escore total, 
bem como evidências de estabilidade da medida (ICC=0,74). A validade convergente foi 
confirmada por correlações significativas positivas entre dimensões similares do Minichal 
e do SF-36, e por correlações significativas negativas com o Minnesota Living with 
Heart Failure Questionnaire - MLHFQ, embora correlações entre constructos dissimilares 
tenham sido observadas. Conclui-se que a versão brasileira do Minichal apresenta 
evidência de confiabilidade e validade, quando aplicada em hipertensos, em seguimento 
ambulatorial.
Descritores: Qualidade de Vida; Questionários; Hipertensão; Psicometria; Estudos de 
Validação; Enfermagem.
Desempeño psicométrico de la versión brasileña del Minicuestionario 
de calidad de vida en la hipertensión arterial (MINICHAL)
Este estudio tuvo como objetivo evaluar la practicidad, la aceptabilidad, los efectos techo 
y suelo, la confiabilidad y la validez de constructo convergente de la versión brasileña del 
Minicuestionario de Calidad de Vida de la Hipertensión Arterial - MINICHAL. Participaron 
del estudio 200 pacientes hipertensos en seguimiento en ambulatorio, en hospital 
universitario y en Unidad Básica de Salud. El MINICHAL fue aplicado en 3,0 (±1,0) 
minutos, con 100% de los ítems respondidos. Fue observado “efecto techo” en ambas 
dimensiones y puntaje total, así como evidencias de estabilidad de la medida (CCI=0,74). 
La validez convergente fue confirmada por correlaciones significativas positivas entre 
dimensiones similares del MINICHAL y del SF-36, y por correlaciones significativas 
negativas con el Minnesota Living with Heart Failure Questionnaire - MLHFQ, a pesar de 
que correlaciones entre constructos no similares hubiesen sido observadas. Se concluye 
que la versión brasileña del MINICHAL presenta evidencia de confiabilidad y validez 
cuando aplicada en hipertensos en seguimiento en ambulatorio.
Descriptores: Cuestionarios de Calidad de Vida; Hipertensión; Psicometría; Estudios de 
Validación; Enfermería.
Introduction
Hypertension, considered a major risk factor for 
cardiovascular disease(1), affects about one billion 
people worldwide(2). In Brazil, population-based 
surveys conducted in Southeastern and Southern cities 
showed a prevalence of between 22.3% and 43.9% 
of hypertensive individuals(3). Besides the recognition 
and control of hypertension and its effects on morbidity 
and mortality, the evaluation of the health related 
quality of life (HRQoL) has been considered another 
important measure of outcome in treating hypertensive 
patients(4). Studies have reported worse HRQoL among 
hypertensive individuals compared with those without 
hypertension(5), which has been attributed to factors 
such as adverse effects related to the pharmacological 
therapy(6), stigma associated with recognition by 
the subject of the hypertension - called the labeling 
effect(7), as well as symptoms arising from diastolic 
heart failure(8).
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The literature reports few specific instruments 
for evaluating HRQoL in hypertensive individuals, 
highlighting the Questionnaire for the Assessment of 
Quality of Life of Bulpitt and Fletcher(9), the Arterial 
Hypertension Quality of Life Questionnaire – the Calidad 
de Vida en la Hipertensión Arterial – CHAL, developed 
in Spain(10) and its abbreviated version – the Mini-
Cuestionario de Calidad de Vida en la Hipertensión 
Arterial - MINICHAL(11), and the Hyper 31, a self-applied 
instrument developed in Italy(12). Of these, the Bulpitt 
and Fletcher questionnaire(13) and MINICHAL(14) have 
been adapted to the Portuguese language of Brazil. 
While the Bulpitt and Fletcher questionnaire(9) evaluates 
the physical well-being (symptoms), psychological well-
being and especially the perception of the effects of 
pharmacological treatment in the lifestyle of hypertensive 
outpatients(9), the MINICHAL aims to evaluate the 
involvement of the somatic and mental dimensions 
of the health of hypertensive patients, without giving 
importance to the perception of the impact of the 
pharmacological treatment in the life of the subject.
In the study of adaptation of the MINICHAL for the 
Brazilian culture some aspects of reliability and validity 
of the Brazilian version were analyzed, with an analysis 
of its internal consistency and its factors to evaluate 
its construct validity as well as the evaluation of the 
capacity of the MINICHAL in discriminating between 
HRQoL of hypertensive and normotensive individuals(14), 
for analysis of its criterion validity. The properties 
evaluated in the study of adaptation although important, 
were not exhaustive. When using an instrument in the 
clinical practice or in research it is very important to have 
the most comprehensive information possible about its 
psychometric performance, its strength and limitations, 
for the correct interpretation of the results obtained 
with the measurement. Thus, this study proposes to 
amplify the evaluation of the psychometric properties 
of the Brazilian version of the MINICHAL with regard to 
measurement stability and convergent construct validity. 
It is hoped that the results of this study will contribute 
to the refinement of the specified questionnaire to 
measure HRQoL in hypertension, aiming to its future use 
in evaluating the impact of nursing interventions on the 
HRQoL of hypertensive outpatients.
Aim
This study aimed to evaluate the feasibility, 
acceptability, ceiling and floor effects, temporal stability 
and the convergent construct validity of the Brazilian 
version of the Mini-Cuestionario de Calidad de Vida en 
la Hipertensión Arterial - MINICHAL when applied in 
hypertensive outpatients, in a University Hospital and a 
Primary Health Unit
Methods
Study site
The research was conducted at the Hypertension 
Outpatient Clinic of a large university hospital and in a 
Primary Health Unit, both in the State of São Paulo.
Subjects
The subjects of this study were 200 hypertensive 
outpatients aged over 18 years followed in the referred 
services for more than six months. Patients with 
secondary hypertension, co-morbidities that impacted 
on the HRQoL (Terminal Chronic Renal Disease and 
Neoplasia) and chronic pneumopathy not related to 
hypertension (in order to exclude patients with dyspnea 
unrelated to hypertension), as well as those that 
presented an inability to comprehend and communicate 
verbally were excluded. The sample size was estimated 
by the difference between the means in the domains of 
the MINICHAL, obtained from the pilot study analysis 
(n=32). Considering α=0.05 and β=0.20, a minimum 
sample of 200 subjects was estimated.
Data Collection
Data collection was conducted from May to 
December 2009. Data were collected through individual 
interviews, according to the following steps:
- First Step: the registration of available charge 
information was used to obtain the sociodemographic 
and clinical data of the subjects, followed by a structured 
interview to obtain sociodemographic and clinical data 
not available in the hospital records, as well as for the 
measurement of HRQoL;
- Second Step: seven days after the first application, the 
MINICHAL was applied again (re-test) in a proportion 
of the subjects (n=60) who participated in the first 
application (test).
To collect data relative to the HRQoL, the Brazilian 
versions of the Medical Outcomes Study 36-Item Short-
Form Health Survey - SF-36, of the Minnesota Living with 
Heart Failure Questionnaire - MLHFQ and the MINICHAL 
were used. It is noteworthy that all the instruments 
were administered through an interview, due to the low 
education level of the subjects enrolled (mean of 6 and 
median of 4 years of schooling).
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Medical Outcomes Study 36-Item Short-Form Health 
Survey (SF-36)
This is a generic questionnaire developed to 
measure HRQoL, self-administered, multidimensional and 
adapted to the Brazilian culture by Ciconelli in 1999(15). 
It comprises 36 items grouped into eight domains or 
components: Physical functioning (10 items), Role-
physical (four items), Pain (two items), General Health 
Perception (five items), Vitality (four items), Social 
Functioning, (two items), Role-Emotional (three items), 
Mental Health (five items) and one Health Transition item 
comparing current health condition to health condition 1 
year earlier. Each dimension is individually analyzed, and 
scores on the eight components may range from 0 to 
100, with higher scores indicating better health status.
Minnesota Living with Heart Failure Questionnaire - 
MLHFQ
The Brazilian version of the MLHFQ, adapted 
for the Brazilian culture by Carrara(16) was used. The 
MLHFQ was developed by Rector et al., in 1987(17) 
in order to evaluate the HRQoL of patients suffering 
from heart failure, considering the self-assessment of 
the patient regarding the impact of the disease and 
of its treatment. It is composed of 21 items that refer 
to the limitations associated with heart failure, which 
impeach the patient from living as he would like in 
the last month. The 21 items are distributed in the 
dimensions - Physical and Emotional and in a set of 
non-grouped responses, which are involved only in 
the total score. A value from 0 (zero) to 5 (five) can 
be assigned for each item, where zero corresponds to 
the best and five to the worst HRQoL. The total score 
is obtained by the sum of the 21 items, ranging from 
zero to 105(17). Although constructed for evaluating the 
HRQoL in patients with heart failure, the items of the 
MLHFQ are based on the perception of the symptoms, 
especially fatigue and dyspnea, which allows its use 
with hypertensive patients.
Mini-Cuestionario de Calidad de Vida en la Hipertensión 
Arterial - MINICHAL
A version adapted to the Portuguese of Brazil(14) was 
used, which is the shortened version(18) of the Calidad de 
Vida en la Hipertensión Arterial – CHAL, developed (10) and 
validated in Spain(11). It is a self-administered instrument 
consisting of 16 items divided into two dimensions: 
State of Mind, composed of 10 items (questions 1 to 10) 
and Somatic Manifestations, which includes six items 
(questions 11 to 16), and a general QoL question which 
does not appear in either of the dimensions and is used to 
evaluate the responsiveness of the instrument, with four 
possible answers on a Likert-type scale of four points: 0 
(No, not at all), 1 (Yes, a little), 2 (Yes, quite a lot), and 3 
(Yes, very much). The answer to each of the items refers 
to the last seven days. The total score is obtained from 
the sum of all items and ranges from zero (best health 
level) to 48 (worst health level)(18). It is noteworthy that 
in the validation study of the MINICHAL for the Brazilian 
culture, item 10 was excluded from the dimension 
State of Mind and included in the dimension Somatic 
Manifestations, and the question referring to the general 
perception of the health of the patient was included as a 
17th question(14). In the present study the composition of 
the dimensions and respective scores established in the 
creation of MINICHAL(18) were considered.
Data Analysis
The data obtained from the application of the 
instruments were transported to the program Excel for 
Windows/2003 and then to the program SAS (Statistical 
Analysis System) for Windows, version 9.02, for the 
current analysis:
Ceiling and floor effects, feasibility and acceptability
The percentage of patients who scored at floor 
level (equivalent to the worse 10% of the results of the 
scale, i.e. score ≥27 for the State of Mind dimension, 
≥16.2 for the Somatic Manifestations dimension and 
≥43.2 for the total score) or ceiling level (equivalent 
to the best possible 10% of the results of the scale, i.e. 
score ≤3 for the Mental State dimension, ≤1.8 for the 
Somatic Manifestations dimension and ≤4.8 for the total 
score)(19) were evaluated. Ceiling and floor effects were 
considered substantial if greater than 25%(20).
The feasibility of the MINICHAL was evaluated from 
the time spent on the application of the instrument. The 
viability/acceptability was evaluated from the percentage 
of unanswered items and from the proportion of patients 
that did not respond to all the items(21).
Reliability
The reliability was evaluated with regard to the 
measurement stability, i.e. the concordance between 
repeated measurements (test-retest), through the Intra-
class correlation coefficient (ICC). An ICC >0.70 was 
considered as evidence of measurement stability(22).
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Construct validity
The convergent construct validity was assessed 
using the Spearman correlation coefficient between the 
scores of the Brazilian versions of the MINICHAL, the 
MLHFQ and the SF-36. Correlation coefficients <0.30 
were considered of low magnitude, between 0.30 and 
0.50 of moderate magnitude, and >0.50 of strong 
magnitude, as recommended by Ajzen and Fishbein(23). 
Based on a previous study(24), negative significant 
correlations of high magnitude (>0.50) between the 
dimensions and the total score of the MINICHAL and 
the conceptually similar domains of the SF-36 (in the 
evaluation of the scores of the MINICHAL, the higher 
the score, the better the HRQoL) and significant positive 
correlations of high magnitude between the dimensions 
of the MINICHAL and similar dimensions of the MLHFQ 
were hypothesized. Correlations of moderate to low 
magnitude were hypothesized between conceptually 
divergent dimensions. The findings were considered 
significant when the p-value ≤0.05.
Ethical considerations
The study was approved by the local ethics 
committee (Protocol no. 1083/2008). The researcher 
explained the purpose of the study to the eligible patients 
and invited them to participate. The usual guarantees of 
confidentiality were given and written informed consent 
was obtained from all patients.
Results
Sociodemographic and clinical data
The sample (n=200) was composed mostly of 
women (58.0%) with mean age of 57 (±11.3) years, 
Caucasian (64.5%), married (61.5%), with a mean of 
6 (±4.1) years of study, active (59.0%), with individual 
and family income means of 1.6 (±1.5) and 3.2 (±2.1) 
minimal wages, respectively. The sociodemographic 
and clinical characteristics of the subjects studied are 
presented in Table 1.
Table 1 - Sociodemographic and clinical characteristics of hypertensive patients (n=200) in outpatient at the university 
hospital and the Primary Health Unit. Campinas, SP, Brazil, 2010
Sociodemographic Variables n % Mean (sd) Median Variation
Age (years) 57 (11.3) 57 21-82
Gender
Female 116 58
Race (n=198)
Caucasian 129 64.5
Schooling (years) 6 (4.1) 4 0-16
Marital Status
Married 123 61.5
Separated/Divorced/Cohabiting 28 14
Widowed 27 13.5
Single 22 11
Employment status (n=198)
Retired 81 40.5
Working 76 38.0
Housework 42 21.0
Income
Individual monthly income (MW*) (n=199) 1.6 (1.5) 1.29 0,0-8,6
Family monthly income (MW*) (n=197) 3.2 (2.1) 2.58 0,0-12,9
Clinical variables
Length of hypertension (years) 12.6 (10.5) 10 1-53
Risk Factors and/or Associated Clinical Conditions
Dyslipidemia 133 66.5
Abdominal obesity † 132 66.0
Family history of CVD ‡ 117 58.5
Obesity (Body Mass Index>30) 90 45.0
Metabolic Syndrome 82 41.0
Glucose intolerance § 55 27.5
Hyperuricemia || 31 15.5
Smoker (current) 21 10.5
(continue...)
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Sociodemographic Variables n % Mean (sd) Median Variation
Number of co-morbidities 3.1 (1.7) 3 0-7
CVD ‡
Left ventricular hypertrophy ** 85 42.5
Coronary heart disease and/or myocardial revascularization 26 13.0
Heart Failure 12 6.0
Stroke 9 4.5
Carotid intimal-medial thickness †† and/or transient cerebral ischemia 7 3.5
Peripheral arteriopathy 6 3.0
Symptoms
Headache 94 47.0
Edema 87 43.5
Arrhythmia 71 35.5
Lipothymia 57 28.5
Dyspnea 57 28.5
Angina 54 27.0
Number of associated symptoms 2.1 (1.6) 2 0-6
Number of medications in use 3.6 (2.4) 3 0-11
Table 1 - (continuation)
*MW = minimum wage. One (1) minimum wage = R$465.00, value of the minimum wage in the period of data collection; †WC >102 cm for men and >88 
cm for women, ‡CVD: Cardiovascular Disease; § glycemia between 102-125 mg/dl; || uric acid >7 mg/dl for men and >6.5 mg/dl for women; **LVH ≥125g/
m2 for men and ≥110 g/m2 for women); ††intima-media thickness >0.9mm
The group studied was characterized by the mean 
length of 12.6 (±10.5) years of hypertension history, 
with 3.09 (±1.7) associated clinical conditions, especially 
dyslipidemia (66.5%), abdominal obesity (66.0%) 
and family history of CVD (58.5%). Only 13.0% of the 
sample reported coronariopathy and/or myocardial 
revascularization. A mean of 2.1 (±1.6) associated 
symptoms was obtained, with reports of headache 
(47.0%) and edema (43.5%) being more frequent.
Feasibility, acceptability, ceiling and floor effects and 
descriptive measures of HRQoL
The mean length of application of the MINICHAL 
was 3.01 (±1.05) minutes, ranging from 1.1 to 8.1 
minutes with a median of 2.5 minutes. All patients 
answered 100% of the items of the MINICHAL in the 
first application. The measurements of HRQoL obtained 
from the application of the generic instrument (SF-36) 
and the specific instruments (MLHFQ and MINICHAL), as 
well as the results of the evaluation of the ceiling and 
floor effects are presented in Table 2.
Table 2 - Descriptive measurements of the SF-36, MLHFQ and the Brazilian version of the MINICHAL and floor and 
ceiling effects (n=200). Campinas, SP, Brazil, 2010.
Measures of HRQoL Mean (sd) Median Observed range Possible range Floor effect (%) Ceiling effect (%)
SF-36
Physical functioning 65.2 (26.7) 65.0 0-100 0-100 3.5 29
Role-physical 57.8 (39) 75.0 0-100 0-100 19.5 35.5
Pain 56.5 (27.1) 57.5 0-100 0-100 5 16.5
General Health Perception 63.5 (24) 67.0 0-100 0-100 2.5 18
Vitality 61.3 (23.0) 65.0 5-100 0-100 2 15
Social functioning 70.6 (27.5) 75.0 0-100 0-100 2 32
Role-emotional 57.5 (39.6) 66.7 0-100 0-100 22.5 37.5
Mental Health 64.2 (25.3) 68.0 4-100 0-100 1.5 20.5
MLHFQ
MLHFQ – Physical 8.9 (8.2) 7.0 0-29 0-40 - 42
MLHFQ - Emotional 5.8 (5.4) 4.0 0-25 0-25 1 34.5
MLHFQ – Total 21.5 (17.7) 16.0 0-72 0-105 - 32.5
MINICHAL
Mental State 6.7 (5.4) 5.0 0-30 0-30 1 31.5
Somatic Manifestations 3.4 (2.6) 3.0 0-12 0-18 - 25.5
Total Score 10.2 (7.0) 8.0 0-37 0-48 - 22.5
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Analysis of the distribution of the scores of 
the MINICHAL in the study population revealed the 
occurrence of a moderate ceiling effect in the MINICHAL 
total (22.5%) and substantial ceiling effect in the Mental 
State (31.5%) and Somatic Manifestations (25.5%) 
dimensions. No floor effect was observed.
Reliability - measurement stability
The measurement stability was assessed using 
the Intra-class Correlation Coefficient (ICC) in patients 
undergoing the re-test (n=60). The analysis indicated an 
ICC = 0.74 for the total score, 0.78 for the Mental Status 
dimension, and 0.64 for the Somatic Manifestations 
dimension.
Construct validity
The construct validity of the Brazilian version of the 
MINICHAL was demonstrated by the correlation between 
the scores of the MINICHAL and the generic (SF-36) and 
specific (MLHFQ) HRQoL measurements. Correlations 
between the similar dimensions of the MINICHAL and 
the dimensions of the SF-36 and MLHFQ are presented 
in Table 3.
Table 3 – Spearman’s correlation coefficients of the Brazilian MINICHAL domains with SF-36 and MLHFQ dimensions 
(n=200). Campinas, SP, Brasil, 2010
HRQoL instruments
MINICHAL 
Somatic manifestations Mental state Item 17 Total score
SF-36
Physical functioning -0.51* -0.42* - 0.30* -0.52*
Role-physical -0.42* -0.47* - 0.31* -0.52*
Pain -0.46* -0.41* - 0.19† -0.49*
General Health Perceptions -0.38* -0.51* - 0.35* -0.53*
Vitality -0.45* -0.61* - 0.31* -0.63*
Social functioning -0.26* -0.52* - 0.22* -0.47†
Role-emotional -0.34* -0.48* - 0.29* -0.49*
Mental Health -0.40* -0.62* - 0.33* -0.62*
MLHFQ
MLHFQ – Physical 0.60* 0.64* 0.40* 0.73*
MLHFQ – Emotional 0.42* 0.60* 0.33* 0.62*
MLHFQ – Total 0.58* 0.68* 0.43* 0.75*
*p<0.001; †p<0.01
As previously hypothesized, strong magnitude 
correlations were observed between the MINICHAL-
total and all dimensions/domains of the MLHFQ and 
SF-36, except for the Pain (r=-0.49), Social functioning 
(r=-0.47) and Role-emotional (r=-0.49) domains of 
the SF-36, where the correlations were of moderate 
magnitude. The State of Mind dimension of the 
MINICHAL was strongly correlated with the Vitality (r=-
0.61) and General Health Perception (r=-0.51) domains 
of the SF-36, whereas moderate magnitude correlations 
were observed between the Somatic Manifestations 
dimension of the MINICHAL and the Vitality (r=-0.45) 
and General Health Perception (r=-0.38) domains of 
the SF-36.
Considering the analysis between similar 
dimensions, strong magnitude correlations were found 
between the dimension Somatic Manifestations of 
the MINICHAL, the physical dimension of the MLHFQ 
(r=0.60) and the Physical functioning domain of the 
SF-36 (r=-0.60), as previously hypothesized. Moderate 
magnitude correlations were found between the 
Somatic Manifestations dimension of the MINICHAL 
and the Role-physical (r=-0.42) and Pain (r=-0.36) 
domains of the SF-36. The State of Mind dimension of 
the MINICHAL presented strong magnitude correlations 
with the Emotional dimension of the MLHFQ and the 
Mental Health (r=0.62) and Social functioning (r=0.52) 
domains of the SF-36 and a moderate magnitude 
correlation with the Role-emotional domain of the SF-
36 (r=0.48).
However, when considering the relationship between 
dissimilar constructs, a strong correlation was observed 
between the State of Mind dimension of the Brazilian 
version of the MINICHAL and the Physical dimension of 
the MLHFQ (r=0.64).
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Discussion
The findings of this study indicate evidence of 
feasibility and viability/acceptability of the Brazilian 
version of the MINICHAL, characterized by the low 
onus on the respondent, i.e. the mean application time 
of 3.0 (±1.0) minutes, with 100% of items answered 
in the first application. In the original study of the 
MINICHAL(18), in which the instrument was completed 
by the respondent, the mean application time was 7.2 
(6.5) minutes and 5.7% of the patients did not answer 
all items. The analysis of the distribution of the scores 
of the Brazilian version of the MINICHAL in the study 
population revealed a moderate ceiling effect in the 
MINICHAL total (22.5%) and a substantial ceiling effect 
in the State of Mind (31.5%) and Somatic Manifestations 
(25.5%) dimensions, as well as an absence of floor 
effect. The ceiling effect occurs when the distribution 
of the scores is asymmetric and a certain percentage of 
the population score at the higher level of the measure, 
which prevents the detection of changes in health status 
in situations of health improvement in the population 
evaluated. The floor effect manifests itself when a 
percentage of subjects score in the lower level of the 
measure, which prevents detection by the instrument of 
changes regarding situations of worsening health of the 
studied population(19). The occurrence of these effects 
may indicate impairment of psychometric properties, 
such as sensitivity - the ability of the instrument to 
measure any change in health status, regardless of 
its magnitude, and responsiveness - the ability of the 
instrument to measure the magnitude of health status 
change in the study population(25). It was therefore 
observed that the Brazilian version of the MINICHAL 
can be potentially sensitive and responsive to the 
measurement of worsening, since the floor effect was 
rarely observed, but may have a reduced potential for 
measuring improvement, since the presence was verified 
of a substantial ceiling effect in both dimensions and a 
moderate effect in the total score. The analysis pointed 
to the satisfactory reproducibility of the Brazilian version 
of the MINICHAL, with similar ICC values found in the 
Spanish validation study of the MINICHAL (ICC = 0.70 
in the State of Mind dimension, and 0.68 in the Somatic 
Manifestations dimension)(18).
In the present study evidence was observed of 
convergent validity of the MINICHAL, since moderate 
to strong magnitude correlations were found between 
similar domains. Correlations of moderate magnitude 
found between the State of Mind dimension of the 
MINICHAL and the Role-emotional domain of the SF-36 
and between the Somatic Manifestations dimension of 
the MINICHAL and Role-physical and Pain domains of 
the SF-36, can be explained by the fact that the items 
comprising the physical dimension of the SF-36 and of 
the MINICHAL are distinct. It was observed that the items 
that comprise the Role-physical domain of the SF-36 are 
intended to evaluate the perception of the limitations 
due to the presence of symptoms, and the items that 
comprise the Somatic Manifestations dimension of the 
MINICHAL evaluate the perception of the symptoms 
related to hypertension without, however, evaluating the 
perception of limitation imposed by the symptom on the 
performance of daily living activities. Likewise, items that 
constitute the Role-Emotional domain of the SF-36 refer 
to the limitations imposed by the emotional aspects, 
while the State of Mind dimension of the MINICHAL 
refers to the perception of signs/symptoms by the 
subject, regardless of their impact on the performance 
of daily living activities. However, correlations between 
dissimilar domains were observed, particularly between 
the State of Mind dimension of the MINICHAL and the 
Physical dimension of the MLHFQ.
A previous study(26), which tested the convergent 
validity of the Brazilian version of the MINICHAL through 
correlation with a generic HRQoL measure, also found 
a strong magnitude correlation (r=0.53) between the 
State of Mind domain of the MINICHAL and the Physical 
dimension of the generic measure of HRQoL, although 
in this study the composition of factors suggested in 
the adaptation study of the MINICHAL for the Brazilian 
culture was used, in which item 10 is considered 
in the composition of the State of Mind dimension. 
Thus, one possible explanation for these findings may 
be related to the factorial composition of the original 
MINICHAL with the allocation of items in the State of 
Mind dimension, where the interpretation may suggest 
disease repercussions in the somatic dimension and not 
in the emotional dimension, as previously hypothesized. 
Therefore, item 9 of the MINICHAL - Do you feel worn out 
and without energy? - may have been interpreted by the 
subjects, as the presence of “weakness” and “fatigue” 
symptoms often mentioned by hypertensive patients 
and thus, with repercussions in the physical dimension 
of the HRQoL. Similarly, item 10 of the MINICHAL - have 
you felt sick? - may have been interpreted as a physical 
or emotional repercussion of the disease in the life of 
the subject. Additionally, the impact of the disease in 
the life of the subject assessed by item 7 – “Making 
your relationships or activities with family members and 
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friends difficult” that constitutes the physical dimension 
of the MLHFQ approaches the repercussions evaluated 
by items 2 and 3 (“Have you had difficulty maintaining 
your normal social relationships?” and “Have you had 
difficulty in relating to people?”, respectively), which 
constitute the State of Mind dimension of the Brazilian 
version of the MINICHAL, which could explain the 
magnitude of the correlation found between the State 
of Mind dimension of the MINICHAL and the Physical 
dimension of the MLHFQ. Thus, the results regarding the 
convergent validity of the MINICHAL through correlation 
with measures of general and specific HRQoL indicate 
the need for further studies to confirm the structure of 
factors proposed by the original model of the MINICHAL, 
as well as to confirm the proposed factorial composition 
proposed for the Brazilian version of the questionnaire.
Conclusion
The Brazilian version of the MINICHAL showed 
evidence of feasibility, acceptability and potential 
sensitivity for detection of worsening of HRQoL evidenced 
by the lack of floor effect; however, the finding of 
substantial ceiling effects in both dimensions and a 
moderate effect in the total score indicates potential 
limitations in the detection of improvements in HRQoL. 
The convergent validity was partially supported, since 
a strong magnitude correlation was detected between 
similar constructs, but also between dissimilar ones. It 
is recommended that further studies are carried out in 
order to confirm the structure of factors of the Brazilian 
version of the MINICHAL and its convergent validity, as 
well as to investigate its sensitivity and responsiveness.
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